Akero Therapeutics (AKRO) is up 16.6%, or $7.74 to $54.23.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKRO:
- Midday Fly By: Delta beats, PepsiCo names new CFO
- Akero downgraded to Market Perform from Outperform at LifeSci Capital
- Cautious Hold Rating on Akero Therapeutics Amid Novo Nordisk Acquisition and Regulatory Uncertainties
- Cautious Hold Rating on Akero Therapeutics Amid Acquisition Interest and Uncertainties in Efruxifermin’s Clinical Trajectory
- Akero Therapeutics downgraded to Hold from Buy at Jefferies